Tag: Pharmaceutical industry

Eli Lilly, a company based in the United States, may have been a bit late to the game, but they are certainly making up for lost time in the battle of the bulge against...

Pharma bosses, oh boy, let me tell you about them. For America’s politicians, they're like the easiest target to go after. According to Gallup, only a fifth of the country really likes them. That's...

Novo Nordisk's Wegovy weight loss drug, known for its soaring popularity, is now more accessible than ever with a groundbreaking offer directly from the pharmaceutical giant. In an effort to make this blockbuster injection...

Eli Lilly's Multi-Billion Dollar Manufacturing Investment PlanEli Lilly, a pharmaceutical giant based in Indianapolis, Indiana, has recently made headlines with its bold announcement to invest a whopping $27 billion in building four new manufacturing...

Dan Skovronsky, the chief scientific officer at Eli Lilly, is at the forefront of developing groundbreaking obesity drugs. With the success of Zepbound, a weekly shot from the pharmaceutical giant, Skovronsky is now focused...

Bluebird Bio: A Story of Innovation, Struggles, and a New BeginningAfter years of pioneering gene therapies and promising groundbreaking treatments, Bluebird Bio has announced its sale to private equity firms Carlyle and SK Capital...

Biogen's Leqembi Soars, but Profit Forecast Falls ShortBiogen, a renowned biotech company, recently released its fourth-quarter financial results, exceeding revenue and profit expectations thanks to cost-saving efforts and successful new products, notably their groundbreaking...

Investors and Big Pharma Seek New Medicines in ChinaA groundbreaking shift is taking place in the biopharmaceutical industry, as investors and major pharmaceutical companies are increasingly turning to China in search of innovative medicines....

David Joyner, the CEO of CVS Health, stood before the Senate Health, Education, Labor and Pensions Committee in Washington, D.C., on May 10, 2023, to defend pharmacy middlemen like his company's Caremark unit. These...

President Donald Trump has set his sights on Medicare drug price negotiations. While he is not likely to dismantle the negotiation process entirely, he is expected to make significant changes that could impact the...

In the fast-paced world of pharmaceuticals, the landscape has seen a notable shift between 2021 and 2023. During this period, two key sectors within the drugmaking industry experienced contrasting fortunes. On one hand, the...

The Food and Drug Administration recently made a groundbreaking decision to approve Vertex Pharmaceuticals' non-opioid painkiller pill, known as Journavx. This approval marks a significant milestone, as Vertex becomes the first drugmaker in decades...